Healthcare Distribution Alliance – Patients Move Us.
Share Print
About

About

Board of Directors

HDA is governed by a Board of Directors responsible for identification and development of priorities, policies and positions of the organization. The Board of Directors is made up of a corporate officer of each distributor member that chooses to be represented on the Board of Directors.

The president and CEO is an ex officio non-voting member of the Board.

Jon Giacomin
Jon Giacomin
HDA Chairman
Chief Executive Officer, Pharmaceutical Segment
Cardinal Health, Inc.
Dale Smith
Dale Smith
HDA Vice Chairman
Chairman and CEO | H. D. Smith Holding Company
H. D. Smith
Fred Battah
Fred Battah
President
Hospital Pharmaceutical Consulting
Dawn Boyter
Dawn Boyter
Chief Executive Officer
Richie Pharmacal Co., LLC
Paul Dickson
Paul Dickson
President
Morris & Dickson Co., L.L.C.
Greg Drew
Greg Drew, RPh
President
Value Drug Company
Earl English
Earl English
President
CuraScript SD
Michael Faul
Michael Faul
President and CEO
Miami-Luken, Inc.
Louis Ferraro
Louis Ferraro
Vice President, Corporate Commercial Development Group
Henry Schein, Inc.
Jeffrey Foreman
Jeffrey Foreman, R.Ph.
President, Smith Drug Company | President, Burlington Drug Company
Smith Drug Company, Div. J M Smith Corporation
Scott Franklin
Scott Franklin
President
Top Rx
Chad Gielen
Chad Gielen
President/CEO
Louisiana Wholesale Drug Co. Inc.
Michael Holmes
Michael Holmes
CEO Principal Dynamics & CEO QCP
Quality Care Products, LLC
Sam Lazich
Sam Lazich
President
DMS Pharmaceutical Group, Inc.
Nick Loporcaro
Nick Loporcaro
President, McKesson US Pharmaceutical & McKesson Specialty Health
McKesson Corporation